Increasing prevalence of cancer globally is a key factor driving global certified protein chip market revenue growth
Market Size – USD 708.94 Million in 2021, Market Growth – at a CAGR of 7.5%, Market Trends – Well-established protein chip laboratories and research centers in developed regions
The global protein chip market size is expected to reach USD 1370.49 Million at a steady revenue CAGR of 7.5% in 2030, according to latest analysis by Emergen Research. Protein chip market revenue growth can be attributed to factors such as increasing prevalence of cancer globally. Cancer, as one of the most taxing diseases, necessitates functional research in order to comprehend its complicated and heterogeneous nature. Microarray is a sophisticated technology that allows for diagnosis of thousands of genes or RNA products at the same time on a single platform. Proteome chip technology is a unique high-throughput approach for probing a large number of proteins, and it has proven to be a useful tool in cancer research and detection.
The Global Protein chip Market report is dubbed as the first study encompassing the current situation of the Protein chip market that is gravely impacted by the COVID-19 outbreak. The global health emergency has drastically affected the global economy, causing significant repercussions on this particular business sphere. The deadly viral outbreak and the subsequent global lockdown enforcement have beleaguered the Protein chip business landscape. Moreover, it has impeded the developmental scope of various manufacturers and buyers involved in this sector. Thus, the report offers insightful speculations about the post-COVID-19 scenario of the Protein chip industry.
Some Key Highlights From the Report
On 5 January 2022, Illumina and SomaLogic signed a final co-development agreement to deliver the SomaScan Proteomics Assay to Illumina’s existing and future high-throughput Next-generation Sequencing (NGS) platforms. This collaboration will help to accelerate fast-growing high-throughput segment of the proteomics market. Researchers can more effectively and efficiently make biological linkages from genetic sequence (genotype) to cellular function (phenotype) with the scale and speed of Illumina NGS technology, accelerating potential for therapeutic impact.
Analytical microarrays segment is expected to account for largest revenue share over the forecast period. This is attributed to its various benefits offered. In order to evaluate binding affinities, specificities, and levels of protein expression, analytical microarrays are routinely used to profile a complex combination of proteins. This approach involves placing a number of antibodies, aptamers, or affibodies on a glass microscope slide, then identifying the targeted protein using either direct labelling or a reporter antibody in a sandwich test format. The most frequent variety is antibody microarrays, which can be used to profile a complex combination of proteins in order to assess binding affinities, specificities, and protein expression levels.
The antibody characterization segment is expected to account for larger revenue share in the global market over the forecast period, owing to increasing need to determine antibody class, binding kinetics, and epitope specificity, among others. Using autoantibody profiling, protein microarrays are often used to help characterize autoimmune diseases and some malignancies. Antibody characterization is also used in allergy screening assays that measure immune responses to a large number of antigens, cancer biomarker identification or validation that probes high densities of known disease state tissue lysates with specific antibodies or cell types, and epitope mapping for antibody generation.
Academic & research institutes segment is expected to account for larger revenue share over the forecast period. This is attributed to increasing Research & Development (R&D) activities in the field of proteomics. The study of proteins in terms of function, expression, structure, alteration, and interaction in physiological and pathological states is referred to as ‘proteomics’. In the field of proteomics, research on protein chip is one of the major focus of researchers, currently. In the future, it is expected that researchers will be able to create whole relational databases for metabolic and signal transduction pathways using protein chips, and this trend is expected to gain traction in the years to come.
Market in North America is expected to account for largest revenue share during the forecast period, which is attributed to well-established protein chip laboratories and research centers in countries in the region. For example, Yale researchers in the United States developed the world’s first microarray chip for comprehensive protein profiling. The innovative protein chip has the potential to revolutionize protein function research in organisms other than yeast, including humans. Protein interactions are responsible for the majority of development. Diseases can occur when proteins do not interact properly in the body. This technology enables them to comprehend the function of a large number of proteins considerably faster than current methods. This is expected to create possibilities and opportunities for researchers and companies.
Receive a PDF sample copy of the report by logging on to the link here: @ https://www.emergenresearch.com/request-sample/1071
Protein chip Market Segmentation by Product Type:
Technology Outlook (Revenue, USD Million; 2019–2030)
Functional Protein Microarrays
Reverse Phase Protein Microarrays
Application Outlook (Revenue, USD Million; 2019–2030)
End-Use Outlook (Revenue, USD Million; 2019–2030)
Hospitals & Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnological Companies
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/protein-chip-market
Protein chip Market Segmentation by Region:
Rest of APAC
Middle East & Africa
Rest of MEA
The report thoroughly scrutinizes the Protein chip market on the basis of the global market reach and consumer bases of the key geographical segments. Under the regional analysis, the report authors have studied the presence of the global Protein chip market across the major regions and further highlighted their respective market shares, market sizes, revenue contributions, sales networks, distribution channels, and numerous other significant aspects.
The latest research report involves an exhaustive study of the leading companies’ functioning mechanisms participating in this industry. According to our team of analysts, these companies hold a considerable portion of the overall Protein chip market share. Under this section of the report, the principal strategic initiatives led by these companies, including mergers & acquisitions, joint ventures, new business deals, new product launches, collaborations, technological upgradation, and several others, have been emphasized. The top market competitors profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher, Illumina, Inc., Merck KGaA, Arrayit Corporation, PerkinElmer Inc., Quotient, RayBiotech Life, Inc., Thermo Fischer Scientific, Inc.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1071
Key Report Coverage:
The report provides the reader with an in-depth examination of the global Protein chip market, besides performing fundamental data analysis to benefit businesses engaged in this sector.
The prominent factors driving and restraining market growth, latest extensively discussed in the report at length.
The report comprises a broad market categorization based on product type, application gamut, and end-user landscape.
The latest product development, incorporation of new production and distribution techniques, and the company profiles of the market’s major competitors are also included.
Frequently asked questions addressed in the report:
What are the major factors driving the growth of the Global Protein chip Market?
What is the predicted growth rate of the global Protein chip market over the forecast period?
What are the latest trending factors influencing market growth?
What are the risks and challenges existing in the industry?
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Press Release Available @ https://www.emergenresearch.com/press-release/global-protein-chip-market
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
State: British Columbia